Youngjin Pharmaceutical has newly appeared among the top searched stocks.

As of 9:30 AM on the 18th, Youngjin Pharmaceutical is trading at 6,090 KRW, up 0.66% from the previous day. This represents a 15.78% increase compared to May 22. Youngjin Pharmaceutical is known as a specialty pharmaceutical company under the KT&G group, focusing on prescription drugs.

Over the past five days, individual investors have sold a net 30,920 shares, while foreigners and institutions have bought a net 149,553 shares and sold a net 167,634 shares, respectively.

On June 17, Youngjin Pharmaceutical became a market issue with a sharp rise following the approval of dexamethasone as a COVID-19 treatment.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing